ACADIA Pharmaceuticals Inc. vs Micron Technology, Inc. — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while Micron Technology, Inc. trades at $889.2 (market cap $980.90B). The key difference: Micron Technology, Inc. is far larger — about 193.5× ACADIA Pharmaceuticals Inc.'s market cap, and Micron Technology, Inc. pays a 0.06% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | MU | |
|---|---|---|
Market Cap | $5.07B | $980.90B |
Sector | Health | Technology |
52-Week High | $29.41 | $1.21K |
52-Week Low | $20.06 | $115.79 |
Enterprise Value | $4.19B | $961.25B |
Dividend Yield | — | 0.06% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →